Literature DB >> 9771415

Chronic intestinal pseudo-obstruction in systemic lupus erythematosus.

G Perlemuter1, S Chaussade, B Wechsler, P Cacoub, M Dapoigny, A Kahan, P Godeau, D Couturier.   

Abstract

BACKGROUND/AIMS: Chronic intestinal pseudo-obstruction (CIPO) reflects a dysfunction of the visceral smooth muscle or the enteric nervous system. Gastrointestinal manifestations are common in systemic lupus erythematosus (SLE) but CIPO has not been reported. Features of CIPO are reported in five patients with SLE.
METHODS: From 1988 to 1993, five patients with SLE or SLE-like syndrome were hospitalised for gastrointestinal manometric studies. CIPO was the onset feature in two cases. Antroduodenal manometry (three hours fasting, two hours fed) was performed in all patients, and oesophageal manometry in four.
RESULTS: Intestinal hypomotility associated with reduced bladder capacity and bilateral ureteral distension was found in four patients and aperistalsis of the oesophagus in three. Treatment, which consisted of high dose corticosteroids, parenteral nutrition, promotility agents, and antibiotics, led to remission of both CIPO and urinary abnormalities in all cases. Antroduodenal manometry performed in two patients after remission showed increased intestinal motility. One patient died, and postmortem examination showed intestinal vasculitis.
CONCLUSIONS: CIPO in SLE is a life threatening situation that can be reversed by treatment. It may be: (a) a complication or onset feature of the disease; (b) secondary to smooth muscle involvement; (c) associated with ureteral and vesical involvement; (d) the result of intestinal vasculitis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9771415      PMCID: PMC1727185          DOI: 10.1136/gut.43.1.117

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  23 in total

1.  Induction of phase 3 of the migrating motor complex in human small intestine by trimebutine.

Authors:  S Chaussade; S Grandjouan; D Couturier; D Thierman-Duffaud; J F Henry
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

2.  Abnormal postcibal antral and small bowel motility due to neuropathy or myopathy in systemic sclerosis.

Authors:  M P Greydanus; M Camilleri
Journal:  Gastroenterology       Date:  1989-01       Impact factor: 22.682

3.  Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community.

Authors:  C Vitali; S Bombardieri; H M Moutsopoulos; G Balestrieri; W Bencivelli; R M Bernstein; K B Bjerrum; S Braga; J Coll; S de Vita
Journal:  Arthritis Rheum       Date:  1993-03

4.  Chronic intestinal pseudo-obstruction. A report of 27 cases and review of the literature.

Authors:  M D Schuffler; C A Rohrmann; R G Chaffee; D L Brand; J H Delaney; J H Young
Journal:  Medicine (Baltimore)       Date:  1981-05       Impact factor: 1.889

5.  Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults.

Authors:  S D Mann; H S Debinski; M A Kamm
Journal:  Gut       Date:  1997-11       Impact factor: 23.059

Review 6.  Association of chronic interstitial cystitis, protein-losing enteropathy and paralytic ileus with seronegative systemic lupus erythematosus: case report and review of the literature.

Authors:  Q Meulders; C Michel; P Marteau; J D Grange; B Mougenot; P Ronco; F Mignon
Journal:  Clin Nephrol       Date:  1992-05       Impact factor: 0.975

7.  Esophageal dysfunction in patients with mixed connective tissue diseases and systemic lupus erythematosus.

Authors:  F Gutierrez; J E Valenzuela; G R Ehresmann; F P Quismorio; R C Kitridou
Journal:  Dig Dis Sci       Date:  1982-07       Impact factor: 3.199

8.  Erythromycin accelerates gastric emptying by inducing antral contractions and improved gastroduodenal coordination.

Authors:  V Annese; J Janssens; G Vantrappen; J Tack; T L Peeters; P Willemse; E Van Cutsem
Journal:  Gastroenterology       Date:  1992-03       Impact factor: 22.682

9.  Lupus cystitis: primary bladder manifestations of systemic lupus erythematosus.

Authors:  R W Orth; M H Weisman; A H Cohen; L B Talner; D Nachtsheim; N J Zvaifler
Journal:  Ann Intern Med       Date:  1983-03       Impact factor: 25.391

10.  Studies of the pathogenesis of interstitial cystitis, obstructive uropathy, and intestinal malabsorption in a patient with systemic lupus erythematosus.

Authors:  M H Weisman; E C McDanald; C B Wilson
Journal:  Am J Med       Date:  1981-04       Impact factor: 4.965

View more
  12 in total

1.  Primary intestinal autoimmune disease as a cause of chronic intestinal pseudo-obstruction.

Authors:  S Ghirardo; B Sauter; G Levy; I M Fiel; T Schiano; G Gondolesi
Journal:  Gut       Date:  2005-08       Impact factor: 23.059

Review 2.  Gastrointestinal and Hepatic Disease in Systemic Lupus Erythematosus.

Authors:  Brian N Brewer; Diane L Kamen
Journal:  Rheum Dis Clin North Am       Date:  2018-02       Impact factor: 2.670

3.  Gastroparesis in pregnancy: case report and literature review.

Authors:  N Achong; N Fagermo; K Scott; M D'emden
Journal:  Obstet Med       Date:  2011-03-01

4.  Intestinal pseudo-obstruction in patients with systemic lupus erythematosus: a real diagnostic challenge.

Authors:  Carlos Alberto García López; Fernando Laredo-Sánchez; José Malagón-Rangel; Miguel G Flores-Padilla; Haiko Nellen-Hummel
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

5.  Generalized megaviscera of lupus: refractory intestinal pseudo-obstruction, ureterohydronephrosis and megacholedochus.

Authors:  Frederick-D Park; Jeffrey-K Lee; Ganga-D Madduri; Pradipta Ghosh
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

Review 6.  New perspectives in the diagnosis and management of enteric neuropathies.

Authors:  Charles H Knowles; Greger Lindberg; Emanuele Panza; Roberto De Giorgio
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-02-12       Impact factor: 46.802

7.  Chronic intestinal pseudo-obstruction in patients with systemic lupus erythematosus: report of four cases.

Authors:  Federico Ceccato; Adrián Salas; Vanina Góngora; Santiago Ruta; Susana Roverano; Juan Carlos Marcos; Mercedes Garcìa; Sergio Paira
Journal:  Clin Rheumatol       Date:  2007-10-16       Impact factor: 2.980

8.  Intestinal Pseudo-Obstruction as an Initial Manifestation of Systemic Lupus Erythematosus.

Authors:  Dong Jun Oh; Jae Nam Yang; Yun Jeong Lim; Ji Hyuk Kang; Jung Hyun Park; Mal Young Kim
Journal:  Intest Res       Date:  2015-06-09

Review 9.  Intestinal pseudo-obstruction in systemic lupus erythematosus: a case report and review of the literature.

Authors:  Jian-Lin Wang; Gang Liu; Tong Liu; Jiang-Peng Wei
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

10.  Clinical analysis of 61 systemic lupus erythematosus patients with intestinal pseudo-obstruction and/or ureterohydronephrosis: a retrospective observational study.

Authors:  Na Xu; Jiuliang Zhao; Jinjing Liu; Di Wu; Lidan Zhao; Qian Wang; Yong Hou; Mengtao Li; Wen Zhang; Xuejun Zeng; Weigang Fang; Xiaoming Huang; Xuan Zhang; Xinping Tian; Yan Zhao; Xiaofeng Zeng; Fengchun Zhang
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.